FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gangadhar Sunkara

Research Profile

Chemicals & Drugs

Procedures

Physiology

Drug Interactions

Concepts & Ideas

Living Beings

Rats

Co-author Network

Publications

TOP 3
Prafulla Bhad; Surya Ayalasomayajula; Rajesh Karan; Selene Leon; Gillies-Jacques Riviere; Gangadhar Sunkara; Venkateswar Jarugula
Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Uday B Kompella
Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.
Jeffrey Blumer; Donald L Batisky; Thomas Wells; Victor Shi; Susan Solar-Yohay; Gangadhar Sunkara
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gangadhar Sunkara (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Prafulla Bhad; Surya Ayalasomayajula; Rajesh Karan; Selene Leon; Gillies-Jacques Riviere; Gangadhar Sunkara; Venkateswar Jarugula
Evaluation of pharmacokinetic interactions between amlodipine, valsartan, and hydrochlorothiazide in patients with hypertension.
Journal of clinical pharmacology 2011;51(6):933-42.
2010: Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Uday B Kompella
Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor.
Brain research bulletin 2010;81(2-3):327-32.
2009: Jeffrey Blumer; Donald L Batisky; Thomas Wells; Victor Shi; Susan Solar-Yohay; Gangadhar Sunkara
Pharmacokinetics of valsartan in pediatric and adolescent subjects with hypertension.
Journal of clinical pharmacology 2009;49(2):235-41.
2009: Bahru Habtemariam; William Sallas; Gangadhar Sunkara; Steven Kern; Venkateswar Jarugula; Goonaseelan Pillai
Population pharmacokinetics of valsartan in pediatrics.
Drug metabolism and pharmacokinetics 2009;24(2):145-52.
2008: Yan-Ling He; Monica Ligueros-Saylan; Gangadhar Sunkara; Ron Sabo; Charlie Zhao; Yibin Wang; Joelle Campestrini; Francoise Pommier; Kiran Dole; Alan Marion; William P Dole; Dan Howard
Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
Journal of clinical pharmacology 2008;48(1):85-95.
2007: Surya P Ayalasomayajula; Kiran Dole; Yan-Ling He; Monica Ligueros-Saylan; Yibin Wang; Joelle Campestrini; Henri Humbert; Gangadhar Sunkara
Evaluation of the potential for steady-state pharmacokinetic interaction between vildagliptin and simvastatin in healthy subjects.
Current medical research and opinion 2007;23(12):2913-20.
2007: Gangadhar Sunkara; Ron Sabo; Yibin Wang; Yan-Ling He; Joelle Campestrini; Mitchell Rosenberg; Dan Howard; William P Dole
Dose proportionality and the effect of food on vildagliptin, a novel dipeptidyl peptidase IV inhibitor, in healthy volunteers.
Journal of clinical pharmacology 2007;47(9):1152-8.
2007: Yan-Ling He; Ron Sabo; Gangadhar Sunkara; Marie-Noelle Bizot; Gilles-Jacques Riviere; Selene Leon; Monica Ligueros-Saylan; William P Dole; Dan Howard
Evaluation of pharmacokinetic interactions between vildagliptin and digoxin in healthy volunteers.
Journal of clinical pharmacology 2007;47(8):998-1004.
2007: Yan-Ling He; Ron Sabo; Gilles-Jacques Riviere; Gangadhar Sunkara; Selene Leon; Monica Ligueros-Saylan; Mitchell Rosenberg; William P Dole; Dan Howard
Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Current medical research and opinion 2007;23(5):1131-8.
2007: Gangadhar Sunkara; Christine V Reynolds; Francoise Pommier; Henri Humbert; Chingming Yeh; Pratapa Prasad
Evaluation of a pharmacokinetic interaction between valsartan and simvastatin in healthy subjects.
Current medical research and opinion 2007;23(3):631-40.
2004: Helene Sabia; Gangadhar Sunkara; Monica Ligueros-Saylan; Yibin Wang; Harold Smith; James McLeod; Pratapa Prasad
Effect of a selective CYP2C9 inhibitor on the pharmacokinetics of nateglinide in healthy subjects.
European journal of clinical pharmacology 2004;60(6):407-12.
2004: Gangadhar Sunkara; Surya P Ayalasomayajula; Cheruku S Rao; Jonathan L Vennerstrom; Jack DeRuiter; Uday B Kompella
Systemic and ocular pharmacokinetics of N-4-benzoylaminophenylsulfonylglycine (BAPSG), a novel aldose reductase inhibitor.
The Journal of pharmacy and pharmacology 2004;56(3):351-8.
2004: Gangadhar Sunkara; Hilde Bigler; Yibin Wang; Harold Smith; Pratapa Prasad; James McLeod; Monica Ligueros-Saylan
The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
Current medical research and opinion 2004;20(1):41-8.
2003: Rajkumar Conjeevaram; Ayyappa Chaturvedula; Guru V Betageri; Gangadhar Sunkara; Ajay K Banga
Iontophoretic in vivo transdermal delivery of beta-blockers in hairless rats and reduced skin irritation by liposomal formulation.
Pharmaceutical research 2003;20(9):1496-501.
2003: Kavitha Koushik; Gangadhar Sunkara; Peter R Gwilt; Uday B Kompella
Pathways and kinetics of deslorelin degradation in an airway epithelial cell line (Calu-1).
Pharmaceutical research 2003;20(5):779-87.
2002: Jithan V Aukunuru; Gangadhar Sunkara; Surya P Ayalasomayajula; Jack DeRuiter; Randall C Clark; Uday B Kompella
A biodegradable injectable implant sustains systemic and ocular delivery of an aldose reductase inhibitor and ameliorates biochemical changes in a galactose-fed rat model for diabetic complications.
Pharmaceutical research 2002;19(3):278-85.
2001: Gangadhar Sunkara; Uday B Kompella
Controlled release of bioactive materials--28th international symposium. Carbohydrate drug carriers: cyclodextrins and chitosans.
IDrugs : the investigational drugs journal 2001;4(9):1014-6.
2001: Jithan V Aukunuru; Gangadhar Sunkara; Nagesh Bandi; Wallace B Thoreson; Uday B Kompella
Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor.
Pharmaceutical research 2001;18(5):565-72.
2000: Gangadhar Sunkara; Jack DeRuiter; C R Clark; Uday B Kompella
In-vitro hydrolysis, permeability, and ocular uptake of prodrugs of N-[4-(benzoylamino)phenylsulfonyl]glycine, a novel aldose reductase inhibitor.
The Journal of pharmacy and pharmacology 2000;52(9):1113-22.
1999: Uday B Kompella; Gangadhar Sunkara; E Thomas; C R Clark; Jack DeRuiter
Rabbit corneal and conjunctival permeability of the novel aldose reductase inhibitors: N-[[4-(benzoylamino)phenyl] sulphonyl]glycines and N-benzoyl-N-phenylglycines.
The Journal of pharmacy and pharmacology 1999;51(8):921-7.
1999: Gangadhar Sunkara; Christine Navarre; Uday B Kompella
Influence of pH and temperature on kinetics of ceftiofur degradation in aqueous solutions.
The Journal of pharmacy and pharmacology 1999;51(3):249-55.
1999: Christine Navarre; L Zhang; Gangadhar Sunkara; Sue H Duran; Uday B Kompella
Ceftiofur distribution in plasma and joint fluid following regional limb injection in cattle.
Journal of veterinary pharmacology and therapeutics 1999;22(1):13-9.